Cargando…
Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy
Allergen-specific immunotherapy (AIT) is the only causative treatment for allergic diseases by modification of the immune response to allergens. A key feature of AIT is to induce immunotolerance to allergens by generating antigen-specific regulatory T (Treg) cells in allergic patients. Type 1 regula...
Autores principales: | Matsuda, Masaya, Terada, Tetsuya, Kitatani, Kazuyuki, Kawata, Ryo, Nabe, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381954/ https://www.ncbi.nlm.nih.gov/pubmed/35991310 http://dx.doi.org/10.3389/falgy.2022.981126 |
Ejemplares similares
-
Extracellular Vesicles Derived from Allergen Immunotherapy-Treated Mice Suppressed IL-5 Production from Group 2 Innate Lymphoid Cells
por: Matsuda, Masaya, et al.
Publicado: (2022) -
Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
por: Jakwerth, Constanze A., et al.
Publicado: (2022) -
Grand Challenges in Allergen Immunotherapy
por: Cox, Linda
Publicado: (2021) -
Mast Cell Desensitization in Allergen Immunotherapy
por: López-Sanz, Celia, et al.
Publicado: (2022) -
Allergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy?
por: Boonpiyathad, Tadech, et al.
Publicado: (2021)